The Food and Drug Administration (FDA) is delaying its decision on authorizing Moderna's COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation, the Wall Street Journal reported on Friday.
The FDA has been looking into the risk of myocarditis among younger men vaccinated with the Moderna vaccine, after certain Nordic countries limited use of the vaccine, said the report.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)
Read more